established methods of whole blood (Yellow Springs Instrument (YSI) and a hexokinase method on Cobas Bio), and plasma (Kodak Ektachem) glucose measurement, were therefore evaluated for their accuracy and concordance of measurements taken in the neonatal period.
There were substantial discrepancies among the four methods of glucose measurement with wide limits of agreement between these methods. The glucose concentrations measured by HemoCue and YSI (n=206), HemoCue and hexokinase (n=113), HemoCue and plasma glucose on Ektachem (n=69) and hexokinase and Ektachem (n=66) were likely to differ by -29 to +61%, -23 to +56 %, -36 to +65 %, and -19 to +30%, respectively. Even the laboratory methods of blood glucose determination, therefore, can not be used interchangeably.
Using a model based approach, the probabilities of "discordant" classification as hypo-or normo-glycaemia were estimated to be 6.8%, 6.5%, and 7.1% between HemoCue and YSI, HemoCue and hexokinase on Cobas Bio, and HemoCue and Ektachem analysers, respectively.
In view of these low probabilities of discordant classification with other glucose analysers, the HemoCue system may offer a reasonable compromise between bedside and laboratory blood glucose estimations in neonates.
(Arch Dis Child 1996;75:F202-F208) Keywords: blood glucose, hypoglycaemia, haematocrit, HemoCue, Ektachem. Measurement of blood glucose concentration is routinely performed in neonatal intensive care. Newborn infants are vulnerable to disturbances in glucose metabolism during the transition from intrauterine to extrauterine life. '2 This is particularly true of premature and small for dates infants.3 Both hypoglycaemia and hyperglycaemia are common during this period, especially in very low birthweight infants.4
Even asymptomatic hypoglycaemia has been associated with subsequent adverse neurodevelopmental outcome.5 Accurate and rapid determination of blood glucose concentration is therefore a cornerstone in the management of acutely ill infants.
Circulating concentrations of glucose may be measured in plasma or in whole blood, and various assay systems have been developed over the years,6 some of which allow blood glucose estimations to be made at the bedside or in a laboratory adjacent to the patient care area. Strip reagents, used with or without a reflectance meter, were originally developed for ward and home use in diabetic patients, and were quickly adopted for use in babies and children, particularly in neonatal units. Unfortunately, these were primarily developed to measure blood glucose in the normal to high range, and do not perform well in detecting hypoglycaemia in babies.7'-2 Furthermore, they are sensitive to skin cleansing agents and haematocrit which further limit their use in newborn infants.'3-'5 A more fundamental challenge has been the choice of reference laboratory method and it is not even clear that the concept of a "reference method" is valid. The hexokinase method is often taken as the reference,'6 although the one-step glucose dehydrogenase method has been considered superior. It is claimed to be free from interference by a large number of substances, is portable, largely operator independent, and requires only 5 ,ul of blood sample. In view of these apparent advantages, we decided to evaluate it against existing methodologies, and took the opportunity to examine the performance of several laboratory assay systems in routine use, as well as the hexokinase system in our research laboratory.
Methods

COMPARATIVE SYSTEMS
HemoCue B-Glucose This is a photometric system for measurement of whole blood glucose based on a modified glucose dehydrogenase method ( fig 1A) . The system consists of a dedicated photometer which accepts special disposable plastic microcuvettes containing dry chemicals-saponin, mutarotase, glucose dehydrogenase, nicotinamide dinucleotide (NAD), diaphorase and methylthiazolyldiphenyl tetrazolium (MTT). Geometric mean (mmol/1) Geometric mean (mmol/1) The normal neonatal haematocrit (0.45 to 0.60) is rarely found in adults and such high haematocrit values have been shown before to affect the accuracy of blood glucose measurement using various analysers. We therefore evaluated the effect of haematocrit on the agreement between various methods. The haematocrit was determined using the microcentrifugation technique. In those instances where a simultaneous haematocrit determination was not available, the value measured on the same day as the blood glucose determination was used.
STATISTICAL ANALYSIS
The agreement between various pairs of methods was assessed using the method of Bland and Altman"; initial inspection of the data suggested that the glucose concentrations should be logarithmically transformed before analysis, and all subsequent analyses are based on logged values. These analyses show the size of the disagreement, but management of a patient often depends on whether the blood glucose measurement indicates hypoglycaemia, usually defined by a glucose concentration of less than 2.6 mmol/l. Consequently, the clinician will often be interested in the chance that a patient will be classified as hypoglycaemic by one, but not another method. To address this directly and to complement the above analyses, estimates of the probability of discordant classification, using a pair of methods, were obtained on the assumption that the pairs of glucose concentrations followed a bivariate log-normal distribution.21 This assumption was assessed using the approach described by Healy.22 The effect of the haematocrit concentration on the degree of agreement between pairs of methods was assessed by regressing the difference between pairs of logged glucose concentrations against a linear term in haematocrit for the mean, and a log-linear term in haematocrit for the residual standard deviation, using the method of Aitkin.23 Table 2 shows the samples classified by hypo-(<2.6 mmol/l), normo-(2.6-7.0 mmol/ 1), and hyperglycaemic (>7.0 mmol/l) ranges. Assumptions of bivariate log-normality were verified with the appropriate probability plot,22 
Discussion
In this study, we carried out a large scale clinical evaluation of four laboratory methods of blood glucose determination {glucose dehydrogenase (HemoCue), glucose oxidase on whole blood (YSI), glucose oxidase on plasma (Ektachem) and hexokinase (Cobas Bio) in the setting of a neonatal intensive care unit. Our results show a substantial variation between these four methods of blood glucose using the neonatal blood samples. The limits of agreement between the various methods, with the possible exception of the glucose oxidase (Kodak Ektachem) and hexokinase (Cobas Bio) methods, were rather wide. It is therefore clear that these methods of blood glucose 
